-transparent.png){kind=logo}
The use of various doses of metoprolol (spesicor, Leiras, Finland), a selective beta 1-adrenoblocker, in patients with CHD combined with clinical or instrumentally detectable symptoms of bronchial asthma or stage I-II essential hypertension with angina pectoris of I-II functional classes, has shown that metoprolol cardioselective blockade is a relative phenomenon which has definite correlation with a dose, duration of therapy, and the initial status of the bronchopulmonary system. An antianginal effect was observed in 68.5% of patients, an antihypertensive effect--in 71.3%, side-effects--in 6.4%.
Related Publications
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
September 1982,
Hospital practice (Office ed.),
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
August 1972,
The Journal of pharmacology and experimental therapeutics,
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
September 2004,
Orvosi hetilap,
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
January 1985,
Acta medica Scandinavica,
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
February 1980,
Ugeskrift for laeger,
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
October 1975,
British journal of clinical pharmacology,
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
January 1969,
Clinical pharmacology and therapeutics,
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
January 2004,
Anesthesiology,
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
August 1996,
Circulation,
L I Ol'binskaia, and
O A Vartanova, and
A I Sinopal'nikov, and
V G Alekseev, and
O V Logunov
August 1966,
Nature,
